|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
30
|
|
pubmed:dateCreated |
2009-10-19
|
|
pubmed:abstractText |
OEO2 is a randomized, controlled trial of preoperative chemotherapy in patients undergoing radical surgery for esophageal cancer. Random assignment was to surgery alone (S) or to two cycles of combination cisplatin and fluorouracil before surgery (CS). Initial results reported in 2002 demonstrated an advantage for both disease-free and overall survival in the CS group. The analysis has now been updated after a median follow-up of 6 years.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5062-7
|
|
pubmed:dateRevised |
2010-5-21
|
|
pubmed:meshHeading |
pubmed-meshheading:19770374-Adenocarcinoma,
pubmed-meshheading:19770374-Adult,
pubmed-meshheading:19770374-Aged,
pubmed-meshheading:19770374-Aged, 80 and over,
pubmed-meshheading:19770374-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19770374-Carcinoma, Squamous Cell,
pubmed-meshheading:19770374-Cisplatin,
pubmed-meshheading:19770374-Esophageal Neoplasms,
pubmed-meshheading:19770374-Female,
pubmed-meshheading:19770374-Fluorouracil,
pubmed-meshheading:19770374-Follow-Up Studies,
pubmed-meshheading:19770374-Humans,
pubmed-meshheading:19770374-Male,
pubmed-meshheading:19770374-Middle Aged,
pubmed-meshheading:19770374-Neoadjuvant Therapy,
pubmed-meshheading:19770374-Survival Analysis,
pubmed-meshheading:19770374-Time Factors,
pubmed-meshheading:19770374-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.
|
|
pubmed:affiliation |
Department of Surgery, Royal Marsden National Health Services Foundation Trust, London, UK.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
